RXi Pharmaceuticals (RXII) Stock: Climbing On Data Presentation

RXi Pharmaceuticals Corp (NASDAQ: RXII) is climbing in the pre-market hours this morning, and for good reason. The company announced yesterday that it would be attending the 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer. Perhaps more importantly, the company will be presenting. Today, we’ll talk about: The news; what … Read more

RXi Pharmaceuticals (RXII) Stock: Tanking On Offering Announcement

RXi Pharmaceuticals Corp (NASDAQ: RXII) is having an overwhelmingly rough start to the trading session this morning, and for good reason. The company announced that it will be raising funds through a dilutive transaction in a press release early this morning. Of course, the news upset investors, sending the stock tumbling down. Today, we’ll talk … Read more

RXi Pharmaceuticals (RXII) Stock: Headed For The Top On Partnership News

RXi Pharmaceuticals Corp (NASDAQ: RXII) is having an incredibly strong day in the market today, and for good reason. The company announced that it entered into a research collaboration, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about: The collaboration; what we’re seeing from RXII as a … Read more

RXi Pharmaceuticals (RXII) Stock: Gaining On Collaboration

RXi Pharmaceuticals Corp (NASDAQ: RXII) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that it has entered into a research collaboration shortly after the results of a program surrounding RXI-231 were released. Today, we’ll talk about both bits of news, what we’re seeing from … Read more

RXi Pharmaceuticals (RXII) Stock: Gaining Big On Japanese Patent

RXi Pharmaceuticals Corporation (NASDAQ: RXII) RXi Pharmaceuticals is having an overwhelmingly strong day in the market today. After issuing a PR informing investors of a new patent, the stock started to climb dramatically, leading to an alert from our partners at Trade Ideas. At the moment (9:46), RXII is trading at $1.05 per share after … Read more

RXi Pharmaceuticals (RXII) Climbs: What We Can Expect Next

RXi Pharmaceuticals Corporation (NASDAQ: RXII) RXi Pharmaceuticals is having an incredible start in the market today after announcing an update with regard to its candidate RXI-109. Today, we’ll talk about the RXI-109 update, how the market is reacting to the news, and what we can expect to see moving forward. So, let’s get right to … Read more

Big Gainers In Biotech Today | Cleveland BioLabs (CBLI) | RXi Pharmaceuticals Corp (RXII) | Transition Therapeutics (TTHI) | Rockwell Medical (RMTI)

Today has been a good day for the biotech market so far. However, there are always a few stocks that far outpace the rest. I’ve dug up four of them. Here’s what’s happening and what we can expect to see moving forward… Cleveland BioLabs Climbs On Private Placement Agreement Cleveland BioLabs, Inc. (NASDAQ: CBLI) Cleveland … Read more

Dying Stocks Or Emerging Opportunities? MannKind Corporation (MNKD) | Aoxing Pharmaceutical Company (AXN) | RXi Pharmaceuticals Corp (RXII)

This article was originally featured at Warrior Trading News. If you look in the biotech space, some of the biggest conversations are revolving around some of the stocks that are falling today. However, there’s a reason there’s so much conversation about this. While the untrained eye may see dying stocks, many investors are seeing emerging … Read more